News

AddToAny

Google+ Facebook Twitter Twitter

Blood pressure for predicting outcomes

A new method derived from standard blood pressure assessments can improve monitoring of critically ill patients with circulatory shock, it is reported.

The team behind the breakthrough said it accurately predicts risk of death, length of hospital stay and blood lactate levels.

The work involved designing an approach to measure a property of the circulation called the critical closing pressure, which is the blood pressure at which small blood vessels collapse and blood flow stops.

Critical closing pressure can provide an indication of blood vessel tone in response to disease and therapy, but it has not been possible to measure this parameter routinely in clinical care.

Development of the new approach utilised high-resolution waveform data from blood pressure monitoring of 5532 patients in US cardiac intensive care.

Researchers developed an analysis based on measured parameters to define the critical closing pressure.

They then defined a value called tissue perfusion pressure– the difference between average arterial blood pressure and critical closing pressure – and found that it predicted a patient’s risk of death, length of hospital stay and peak blood lactate.

“We have developed a new metric that can identify individuals with inadequate tissue perfusion who are at risk for adverse outcomes. We believe this method can be used to optimise treatment decisions for patients in the intensive care unit,” said Aaron Aguirre, an Assistant Professor of Medicine at Harvard Medical School.

bit.ly/47CNDkH

Image Credit | Istock

Related Articles

girl computer_CREDIT_shutterstock-58872785

Gamification in biomedical science education

Senior Lecturer in Biomedical Science Jen May outlines the successful implementation of scenario-based learning software.

web_blood-testing_credit_istock-1384651794.png

SPONSORED: The power of automated gel-based ID-cards in routine immunohematology workflows

Immuno-haematology assays are pivotal to the carrying out of blood grouping, antibody screening and transfusions, and represent a critically time-dependent stage in the patient management pathway.

Technician holding a blood sample ready for testing with other human medical samples in the background.-Image credit - Science-Photo-Library-f0243823

Machine learning tool to detect cancer via liquid biopsy

US researchers have developed and tested an innovative machine-learning approach that could one day enable the earlier detection of cancer in patients by using smaller blood draws.

multiple myelomatosis-CREDIT-Science Photo Library-m132099

IBMS research grants

We look at the work of Dr Mosavar Farahani who received an IBMS Research Grant in 2023 to help fund her work on disease progression and skeletal complications in multiple myeloma.

Top